Authors:
Davis, ST
Benson, BG
Bramson, HN
Chapman, DE
Dickerson, SH
Dold, KM
Eberwein, DJ
Edelstein, M
Frye, SV
Gampe, RT
Griffin, RJ
Harris, PA
Hassell, AM
Holmes, WD
Hunter, RN
Knick, VB
Lackey, K
Lavejoy, B
Luzzio, MJ
Murray, D
Parker, P
Rocque, WJ
Shewchuk, L
Veal, JM
Walker, DH
Kuyper, LF
Citation: St. Davis et al., Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors, SCIENCE, 291(5501), 2001, pp. 134-137
Authors:
Bramson, HN
Corona, J
Davis, ST
Dickerson, SH
Edelstein, M
Frye, SV
Gampe, RT
Harris, PA
Hassell, A
Holmes, WD
Hunter, RN
Lackey, KE
Lovejoy, B
Luzzio, MJ
Montana, V
Rocque, WJ
Rusnak, D
Shewchuk, L
Veal, JM
Walker, DH
Kuyper, LF
Citation: Hn. Bramson et al., Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): Design, synthesis, enzymatic activities, and X-ray crystallographic analysis, J MED CHEM, 44(25), 2001, pp. 4339-4358
Authors:
Whitlow, M
Howard, AJ
Stewart, D
Hardman, KD
Chan, JH
Baccanari, DP
Tansik, RL
Hong, JS
Kuyper, LF
Citation: M. Whitlow et al., X-ray crystal structures of Candida albicans dihydrofolate reductase: Highresolution ternary complexes in which the dihydronicotinamide moiety of NADPH is displaced by an inhibitor, J MED CHEM, 44(18), 2001, pp. 2928-2932
Authors:
Shewchuk, L
Hassell, A
Wisely, B
Rocque, W
Holmes, W
Veal, J
Kuyper, LF
Citation: L. Shewchuk et al., Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase, J MED CHEM, 43(1), 2000, pp. 133-138
Authors:
Jones, ML
Baccanari, DP
Tansik, RL
Boytos, CM
Rudolph, SK
Kuyper, LF
Citation: Ml. Jones et al., Inhibitors of dihydrofolate reductase: Design, synthesis and antimicrobialactivities of 2,4-diamino-6-methyl-5-ethynylpyrimidines, J HETERO CH, 36(1), 1999, pp. 145-148